Johnson & Johnson (JNJ) holder files to sell 15,918 shares worth $4.09M

Rhea-AI Filing Summary

A shareholder of Johnson & Johnson (JNJ) filed a notice to sell common stock under Rule 144. The planned sale covers 15,918 shares of common stock with an aggregate market value of $4,090,957.06, to be sold on or after 08/06/2026 on the NYSE.

The shares derive from a stock option exercise of 9,344 shares dated 08/06/2026 and multiple restricted stock vesting events between 07/01/2022 and 02/14/2025, totaling 6,574 shares. The filing lists no securities sold during the past three months.

Key Figures

Shares to be sold: 15,918 shares Aggregate market value: $4,090,957.06 Proposed sale date: 08/06/2026 +2 more

5 metrics

Shares to be sold 15,918 shares Common stock proposed for sale under Rule 144

Aggregate market value $4,090,957.06 Total market value of 15,918 shares to be sold

Proposed sale date 08/06/2026 Date on or after which the NYSE sale may occur

Stock option exercise shares 9,344 shares Common stock from stock option exercise dated 08/06/2026

Restricted stock vesting shares 6,574 shares Common stock from vesting events between 07/01/2022 and 02/14/2025

Key Terms

Form 144, Stock Option Exercise, Restricted Stock Vesting

3 terms

Form 144 regulatory

"A shareholder filed a notice to sell common stock under Rule 144."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/06/2026 | Stock Option Exercise | Issuer |"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock Vesting financial

"Common | 07/01/2022 | Restricted Stock Vesting | Issuer |"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 02:03 PM Accepted by SEC EDGAR 08/06/2026 - 02:02 PM Learn about SEC filing dates

FAQ

What size of Johnson & Johnson (JNJ) stock sale does this Form 144 cover?

The Form 144 covers a planned sale of 15,918 shares of Johnson & Johnson common stock with an aggregate market value of $4,090,957.06, as stated in the filing.

When can the Johnson & Johnson (JNJ) shares listed on this Form 144 be sold?

The shares may be sold on or after 08/06/2026. The filing identifies this as the proposed sale date for the 15,918 shares of Johnson & Johnson common stock on the NYSE.

On which exchange are the Johnson & Johnson (JNJ) shares in this Form 144 intended to be sold?

The filing specifies that the 15,918 shares of Johnson & Johnson common stock are proposed to be sold on the NYSE, with an aggregate market value of $4,090,957.06.

How were the Johnson & Johnson (JNJ) shares in this Form 144 acquired?

According to the filing, 9,344 shares came from a stock option exercise dated 08/06/2026, and 6,574 shares came from multiple restricted stock vesting events between 07/01/2022 and 02/14/2025.

Does this Johnson & Johnson (JNJ) Form 144 show any stock sales in the prior three months?

No. The section for Securities Sold During The Past 3 Months does not list any sales, indicating no reported Johnson & Johnson stock sales during that period.

What role does Fidelity Brokerage Services LLC play in this Johnson & Johnson (JNJ) Form 144?

The filing lists Fidelity Brokerage Services LLC with its address in Smithfield, RI, in connection with the 15,918 shares of Johnson & Johnson common stock proposed for sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15918	4090957.06	2409898597	08/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2026	Stock Option Exercise	Issuer			9344	08/06/2026	Cash
Common	07/01/2022	Restricted Stock Vesting	Issuer			1898	07/01/2022	Compensation
Common	02/10/2023	Restricted Stock Vesting	Issuer			642	02/10/2023	Compensation
Common	02/13/2023	Restricted Stock Vesting	Issuer			1631	02/13/2023	Compensation
Common	02/12/2024	Restricted Stock Vesting	Issuer			1825	02/12/2024	Compensation
Common	02/13/2024	Restricted Stock Vesting	Issuer			415	02/13/2024	Compensation
Common	02/14/2025	Restricted Stock Vesting	Issuer			163	02/14/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)